These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35057513)

  • 21. Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway.
    Chen J; Zhao D; Zhu M; Zhang M; Hou X; Ding W; Sun S; Bu W; Feng L; Ma S; Jia X
    Biomed Pharmacother; 2017 May; 89():1362-1369. PubMed ID: 28320103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH.
    Sakasai-Sakai A; Takeda K; Takeuchi M
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.
    Ooi H; Nasu R; Furukawa A; Takeuchi M; Koriyama Y
    Front Pharmacol; 2022; 13():921611. PubMed ID: 35721214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification.
    Yang R; Zhu Y; Wang Y; Ma W; Han X; Wang X; Liu N
    Biochem Biophys Res Commun; 2019 Sep; 517(3):470-476. PubMed ID: 31376939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2.
    Liu H; Yu S; Zhang H; Xu J
    PLoS One; 2012; 7(10):e46720. PubMed ID: 23056421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability.
    Aragonès G; Dasuri K; Olukorede O; Francisco SG; Renneburg C; Kumsta C; Hansen M; Kageyama S; Komatsu M; Rowan S; Volkin J; Workman M; Yang W; Daza P; Ruano D; Dominguez-Martín H; Rodríguez-Navarro JA; Du XL; Brownlee MA; Bejarano E; Taylor A
    Aging Cell; 2020 Nov; 19(11):e13257. PubMed ID: 33146912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
    Takeuchi M; Takino J; Yamagishi S
    Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
    Takeuchi M
    Diagnostics (Basel); 2016 Jun; 6(2):. PubMed ID: 27338481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease.
    Sato T; Shimogaito N; Wu X; Kikuchi S; Yamagishi S; Takeuchi M
    Am J Alzheimers Dis Other Demen; 2006; 21(3):197-208. PubMed ID: 16869341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy Plays a Protective Role in Advanced Glycation End Product-Induced Apoptosis in Cardiomyocytes.
    Hu P; Zhou H; Lu M; Dou L; Bo G; Wu J; Huang S
    Cell Physiol Biochem; 2015; 37(2):697-706. PubMed ID: 26356261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of bovine serum albumin glycation by ribose and fructose in vitro and in vivo.
    Mou L; Hu P; Cao X; Chen Y; Xu Y; He T; Wei Y; He R
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166283. PubMed ID: 34601015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
    Takino J; Kobayashi Y; Takeuchi M
    J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial tethering of LC3 or p62 to organelles is not sufficient to trigger autophagy.
    Loos F; Xie W; Sica V; Bravo-San Pedro JM; Souquère S; Pierron G; Lachkar S; Sauvat A; Petrazzuolo A; Jimenez AJ; Perez F; Maiuri MC; Kepp O; Kroemer G
    Cell Death Dis; 2019 Oct; 10(10):771. PubMed ID: 31601788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor for advanced glycation end products reveals a mechanism regulating thyroid hormone secretion through the SIRT1/Nrf2 pathway.
    Chen XJ; Gong XH; Jie JP; Yu WH; Chen X; Du X; Zhou Q; Wu WJ
    J Cell Biochem; 2019 Mar; 120(3):4582-4598. PubMed ID: 30320918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced Glycation End Products (AGEs) Inhibit Macrophage Efferocytosis of Apoptotic β Cells through Binding to the Receptor for AGEs.
    Mao QY; He SY; Hu QY; Lu Y; Niu YX; Li XY; Zhang HM; Qin L; Su Q
    J Immunol; 2022 Mar; 208(5):1204-1213. PubMed ID: 35173034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes.
    Zhang H; Ge S; He K; Zhao X; Wu Y; Shao Y; Wu X
    Cardiovasc Res; 2019 Dec; 115(14):2008-2020. PubMed ID: 30689742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
    Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
    Schläfli AM; Adams O; Galván JA; Gugger M; Savic S; Bubendorf L; Schmid RA; Becker KF; Tschan MP; Langer R; Berezowska S
    Oncotarget; 2016 Jun; 7(26):39544-39555. PubMed ID: 27250032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D.
    Li Y; Chang Y; Ye N; Dai D; Chen Y; Zhang N; Sun G; Sun Y
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.